tirzepatide results month 1 4 Weigh-In Update on what are the results of
Description
Zepbound (tirzepatide) is a once-weekly subcutaneous injection approved by the FDA for chronic weight management in adults with obesity or overweight with at least one weight-related comorbid condition
40,41 Thus, in the trial programs tirzepatide was started with a dose of 2.5 mg tirzepatide s.c
Your provider may suggest dose adjustments instead
The study found that tirzepatide has superior weight loss outcomes compared to semaglutide
For someone weighing 250 pounds, this could translate to a loss of 37 to 50 pounds, representing a major step toward a healthier life
Tirzepatide influences body weight by reducing appetite, which contributes to a decrease in calorie intake and effective weight management
